Evidence map›Paper›PMID 37530809›Full record

ArticleEuropean radiology2024

An [

Nan Meng, Pengyang Feng, Xuan Yu, Yaping Wu, Fangfang Fu, Ziqiang Li, Yu Luo, Hongna Tan, Jianmin Yuan, Yang Yang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Current trends and future directions of artificial intelligence in lung cancer diagnosis.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Nan Meng *Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Pengyang Feng *Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Xuan Yu *Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Yaping WuDepartment of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Fangfang FuDepartment of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Ziqiang LiDepartment of Medical Imaging, Xinxiang Medical University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China.
Yu LuoDepartment of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Hongna TanDepartment of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China.
Jianmin YuanCentral Research Institute, United Imaging Healthcare Group, Shanghai, China.
Yang YangBeijing United Imaging Research Institute of Intelligent Imaging, United Imaging Healthcare Group, Beijing, China.
Zhe WangCentral Research Institute, United Imaging Healthcare Group, Shanghai, China.
Meiyun WangDepartment of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, 7 Weiwu Road, Zhengzhou, 450000, China. mywang@zzu.edu.cn.
Zhengzhou University · CNHenan Provincial People's Hospital · CNUnited Imaging Healthcare (China) · CNXinxiang Medical University · CN

Funding

the Henan provincial science and technology research projects 212102310689the Henan provincial science and technology research projects 222102310675the Key Project of Henan Province Medical Science and Technology Project LHGJ20190602the Key Project of Henan Province Medical Science and Technology Project LHGJ20210001the Key Project of Henan Province Medical Science and Technology Project LHGJ20210005The National Key R&D Program of China 2017YFE0103600the Natural Science Foundation of Henan Province 202300410081the Zhengzhou Collaborative Innovation Major Project 20XTZX05015
6 · The paper itself

Abstract

objectivesTo develop an [

methodsA total of 145 NSCLC patients (training, 101 cases; test, 44 cases) underwent whole-body [

resultsA prediction model based on random forest, consisting of four clinical factors, six 3D-UTE, and six PET radiomics features, was used as the final model for PET/3D-UTE. The AUCs of this model were 0.912 and 0.791 in the training and test sets, respectively, which not only showed different degrees of improvement over individual models such as clinical, 3D-UTE, and PET (AUC-training = 0.838, 0.834, and 0.828, AUC-test = 0.756, 0.745, and 0.768, respectively) but also achieved the similar diagnostic efficacy as the optimal PET/CT model (AUC-training = 0.890, AUC-test = 0.793). The calibration curves and DCA indicated good consistency (C-index, 0.912) and clinical utility of this model, respectively.

conclusionThe [ CLINICAL RELEVANCE STATEMENT: A machine learning model of KEY POINTS: • The 3D-UTE radiomics model using the PLS-DA classifier was significantly associated with LN status in NSCLC and has similar diagnostic performance as the clinical, CT, and PET models. • The [

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsFluorodeoxyglucose F18HumansLymph NodesMachine LearningMagnetic Resonance ImagingPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiomicsRetrospective StudiesFluorodeoxyglucose F18Lymph node metastasisMachine learningMagnetic resonance imagingNon-small cell lung cancer

Identifiers

PMID37530809
OpenAlexW4385476632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.